Pharmafile Logo

Combating Coronavirus Through Reversing Diabetes

August 10, 2020 | diabetes, obesity, weight loss 

The Diabetes Reversal Company has developed a pioneering programme based on sustainable weight loss, evidence-based lifestyle change and one-to-one clinical support to reduce and reverse the effects of Type 2 diabetes.

The Diabetes Reversal Company has developed a pioneering programme based on weight loss, lifestyle change and one-to-one clinical support to reduce and reverse the effects of Type 2 diabetes, helping deliver the goals in the Government’s newly published National Obesity Strategy.

The strategy aspires to help people lose weight to beat coronavirus and protect the NHS, which is particularly important for people with serious underlying health conditions like Type 2 diabetes who are more at risk. Obesity is a public health time bomb in the UK, over one in four (28.1%) of UK adults are obese, which increases the risk of developing Type 2 diabetes by 80%. The figures show that patients with diabetes make up a third of COVID related deaths in England, with Type 2 diabetes patients two times more likely at risk of dying in hospital.

The Diabetes Reversal Company has developed the world’s first GP led weight loss programme to improve and reverse the effects of Type 2 Diabetes and is accelerating its roll out through a pilot programme with London GP practices. This comes at a time when the Health Secretary Matt Hancock has said the NHS could save £100m over 5 years if everyone lost five pounds.

Company founder Dr Rabbani was inspired by the success of the Diabetes Remission Clinical Trial (DiRECT) to devise a lifestyle programme to help people improve their diabetes care. The three-phase programme of weight loss and lifestyle change has been created in collaboration with specialist NHS doctors, dietitians, and nutritionists, with app-based technology for ongoing monitoring.

Phase one involves fast evidence-based weight loss with an 800 calorie a day diet for eight to twelve weeks, using specially formulated total diet replacements in the form of shakes and soups developed by experts at the Diabetes Reversal Company. The second phase reintegrates healthier versions of the patient’s preferred foods back into their diet with the support of a qualified registered nutritionist. The final phase is based on the Diabetes Reversal Company’s “Golden 5 Plan” focusing on nutrition, movement, sleep, stress management and environmental change to help patients stay healthier for longer.

This innovative work has already delivered proven results. Based on a study of 56 patients over eight to twelve weeks by a qualified nutritionist, patients experienced an average weight loss of 22.6 pounds (10.3 kg) which is over 10% of initial body weight lost and an average BMI decrease of -3.60.

Medical Director and company founder Dr Farhan Rabbani explains the importance on tackling Type 2 diabetes, he said:

“The publication of the Government’s National Obesity Strategy marks an important step forward in tackling the surge of Type 2 diabetes collectively as a nation. The causal link between the risk and severity of COVID-19 and obesity related conditions like Type 2 diabetes means tackling the two go hand in hand.

Our programme offers clinically led solutions that can deliver long term lasting change to people’s weight and feeling of well-being. We want to move away from traditional reliance on medication and start implementing more evidence-based lifestyle changes to help reduce and reverse the effects of Type 2 diabetes”.

This content was provided by Onyx Health

Company Details

 Latest Content from  Onyx Health 

Revolutionising healthcare: The crucial role of diagnostics in transforming the NHS

Amid the formidable challenges faced by the NHS, Onyx Health delve into the pivotal role of diagnostics in healthcare transformation, showcasing how collaboration, innovation, and patient-centric approaches are revolutionising healthcare...

Innovating medical education to deliver 21st century healthcare

Technological advancements are reshaping the healthcare industry. Onyx Health's Medical Education Lead, Sarah Seilly, discusses the innovative techniques at the forefront of enhancing patient care.

Onyx Health Welcomes Sarah Seilly as Head of Medical Education

Leading healthcare marketing communications agency, Onyx Health, has bolstered its team with the appointment of a new Head of Medical Education, Sarah Seilly. This strategic addition to the team reflects...

Onyx Health Expands with Two New Appointments

Newcastle-based creative agency Onyx Health has continued to grow and expand with the dual appointments of Rosie Thompson as Account Manager and Modupe Ayeni as a Medical Writer

Sight-saving MedTech sleep mask could save the NHS multimillions

MedTech company PolyPhotonix has had its innovative diabetes sleep mask adopted in the NHS for the first time

Onyx Health Goes for International Growth with New Managing Director

Onyx Health has announced the appointment of Trevor Pill as their new Managing Director. He will be taking over the day-to-day running of the agency from owner and founder Karen...

Onyx Health Expands with Two New Digital Appointments

Onyx Health has expanded its digital content team with the appointments of Hope Johnston as Digital Content Manager and Jordan Carr as Social Media Executive.

Onyx Health Joins Forces with Rare Disease Specialists Actigen

Onyx Health will be working with Actigen to raise awareness of their innovative clinical trial work in rare diseases and the need to develop new treatment solutions.

Onyx Health Announces a "Double Hatrick" of New Appointments

Onyx Health continues to expand with six new appointments to its creative and communication teams, due to increased growth in its international client portfolio work.

Onyx Health Tackles Type 2 Diabetes with Diabetes Lifestyle Doctors

Onyx Health has teamed up with Diabetes Lifestyle Doctors to tackle the diabetes care gap in the NHS and help patients suffering from type 2 diabetes across the UK. (Pictured...